Ipilimumab is an anti-cancer monoclonal antibody used to treat various cancers, including melanoma and renal cell carcinoma. It works by inhibiting CTLA-4, a protein that downregulates immune responses, thereby enhancing the body's immune response against cancer cells. Ipilimumab is effective in improving survival rates in certain cancer patients. Common side effects may include diarrhea and fatigue, but these usually resolve over time. In summary, Ipilimumab is crucial for managing specific types of cancer.
Ipilimumab blocks CTLA-4, enhancing T-cell activation and proliferation, thereby promoting anti-tumor immune responses.
No published brands for this salt yet.